Relapsing Nephrotic Syndrome Associated with COVID-19

Authors

  • Jusli Aras Department of Pediatrics, Faculty of Medicine, Hasanuddin University/DR Wahidin Sudirohusodo Hospital, Makassar, Indonesia
  • Andi Utari Dwi Rahayu Department of Pediatrics, Faculty of Medicine, Hasanuddin University/DR Wahidin Sudirohusodo Hospital, Makassar, Indonesia
  • Husein Albar Department of Pediatrics, Faculty of Medicine, Hasanuddin University/DR Wahidin Sudirohusodo Hospital, Makassar, Indonesia

DOI:

https://doi.org/10.55175/cdk.v49i6.242

Keywords:

COVID-19, relapsing nephrotic syndrome

Abstract

An 8-year and 2-month-old girl presented with generalized edema for two days with a mild cough and shortness of breath. She was diagnosed with a relapsing nephrotic syndrome (NS) and Community Acquired Pneumonia due to a COVID-19 infection. The patient was discharged with complete remission NS and repeated negative PCR for SARS-CoV-2 from nasopharyngeal swabs. It is important to consider COVID-19 infection as a likely trigger of relapsing NS in children.

Seorang anak perempuan usia 8 tahun 2 bulan masuk rumah sakit dengan keluhan edema anasarka selama 2 hari disertai batuk ringan dan sulit bernapas. Diagnosis adalah sindrom nefrotik relaps, pneumonia COVID-19, dan malnutrisi. Pasien dipulangkan setelah sindrom nefrotik remisi dan hasil PCR SARS-CoV-2 negatif. Infeksi COVID-19 penting dipertimbangkan sebagai pencetus relaps sindrom nefrotik.

Downloads

Download data is not yet available.

References

Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Internat. 1978;13(2):159–65.

McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM. Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol. 2001;16(12):1040–4.

Niaudet P. Steroid-sensitive idiopathic nephrotic syndrome in children. In: Ellis D, William EH, Patrick N, editors. Paediatric nephrology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2004 .pp. 543–56.

Noer MS. Sindrom nefrotik idiopatik. In: Noer MS, et al, editors. Kompendium nefrologi anak. Jakarta: UKK Nefrologi IDAI; 2011. pp. 72-87.

Tarshish P, Tobin JN, Bernstein J, Edelman CM. Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the international study of kidney disease in children. J Am Soc Nephrol. 1997;8:769 –76.

Niaudet P, Boyer O. Idiopathic nephrotic syndrome in children: Clinical aspects. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, editors. Pediatric nephrology vol.1. 6th ed. Springer; 2009. pp. 667-702.

Gipson DS, Massengill SF, Yao L, Nagraj S, Smoyer WE, Mahan JD, et al. Management of childhood onset nephrotic syndrome. Pediatrics 2009;124:747-57.

Gulati S, Kher V, Gupta A, Arora P, Rai PK, Sharman RK. Spectrum of infections in nephrotic syndrome. Pediatr Nephrol. 1995;9:431-4.

Moorani KN, Khan KM, Ramzan A. Infections in children with nephrotic syndrome. J Coll Physicians Surg Pak. 2003;13:337-9.

Iqbal SMJ, Azhar IA, Ahmed TM, Sarfaraz M. The incidence and types of infections in children with nephrotic syndrome. Ann KE Med Coll. 2002;8:105-7.

Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. Chinese pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children. N Engl J Med 2020; 382:1663-1665. https://doi.org/10.1056/NEJMc2005073.

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323(13):1239-42. doi:10.1001/jama.2020.2648

WHO. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19) [Internet]. 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/who- china-joint-mission-on-COVID-19-final-report.pdf.

Livingston E, Bucher K. Coronavirus disease 2019 (COVID- 19) in Italy. JAMA. 2020;323(14):1335. doi:10.1001/jama.2020.4344

Coronavirus Disease 2019 in children - United States, February 12–April 2, 2020.CDC COVID-19 Response Team (2020). MMWR Morb Mortal Wkly Rep. 10;69 (14):422–6.

Red Nacional de Vigilancia Epidemiológica. Situación de COVID- 19 en España. Informe 22 [Internet]. 2020.

Centers for Disease Control and Prevention. If You Are Immunocompromised, Protect Yourself From COVID-19. Coronavirus Disease 2019 (COVID-19). 2020. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html

Ulinski T, Aoun B. Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms. Curr Med Chem 2010;17:847-53.

Coronavirus Disease 2019 (COVID-19) - If You Are Immunocompromised, Protect Yourself From COVID-19. National Institutes of Health. Available at https://www. covid19 treatment guidelines.nih.gov/. Accessed May 30th, 2020.

Moorani KN. Infections are common a cause of relapse in children with nephrotic syndrome. Pak Paed J. 2011;35:213–9.

MacDonald N, Wolfish N, Mclaine P, Phipps P, Rossier E. Role of respiratory viruses in exacerbations of primary nephrotic syndrome. J Paediatr. 1986;108:378–82.

Takahashi S, Wada N, Murakami H, Funaki S, Inagaki T, Harada K, et al. Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndrome. Pediatr Nephrol. 2007;22:232–6.

Uwaezuoke SN. Steroid-sensitive nephrotic syndrome in children: Triggers of relapse and evolving hypotheses on pathogenesis. Ital J Pediatr 2015;41:19.

Jiang Y, Xu BP, Jin RM, et al. Expert consensus on diagnosis, treatment and prevention of novel coronavirus infection in pediatrics (first edition) [Standard Programme Guideline]. Chin J Appl Clin Pediatr. 2020;35(2): 81-85

Fang F, Luo XP. Facing 2019 novel coronavirus infections: a pediatrician’s thinking. Clin J Pediatr. 2020;58(2):81-85. https://doi.org/10.3760/cma.j.is sn.0578-1310.2020.02.001

WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020; https://www.who.int/docs/default-source/coronaviruse/ who-chinajoint-mission-on-COVID-19-final-report.pdf.

COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed May 30th, 2020.

Melgosa M, Madrid A, Alvárez O, Lumbreras J, Nieto F, Parada E, Perez-Beltrán V,. SARS-CoV-2 infection in Spanish children with chronic kidney pathologies. Pediatr.Nephrol. 2020;35:1521–4 https://doi.org/10.1007/s00467-020-04597-1.

Kanne JP.. Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist. Radiology 2020. 295(1): 16-17.

Ai Tao et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020. doi: 10.1148/radiol.2020200642

Tahamtan A, Ardebili A. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev Mol Diagn. 2020;20(5):453-454. doi: 10.1080 /14737159.2020 .1757437

Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts.medRxiv. 2020. https://doi.org/10.1101/2020.03. 03.20028423.

Downloads

Published

01-06-2022

How to Cite

Aras, J., Dwi Rahayu, A. U., & Albar, H. (2022). Relapsing Nephrotic Syndrome Associated with COVID-19. Cermin Dunia Kedokteran, 49(6), 332–334. https://doi.org/10.55175/cdk.v49i6.242

Issue

Section

Articles